L'Oréal Says GLP-1 Drugs Are Now Moving Skin Care Sales
L'Oréal CEO Nicolas Hieronimus says GLP-1 drugs are 'having an impact' on skin care consumption as the group posts 7.2% Q3 sales growth to €11.6bn.
Topic
Skin Sagging
Topic
Topic
Topic
L'Oréal CEO Nicolas Hieronimus says GLP-1 drugs are 'having an impact' on skin care consumption as the group posts 7.2% Q3 sales growth to €11.6bn.